Form Type: 4

SEC EDGAR Link
Accession Number:0001209191-19-057850
Date:2019-11-20
Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
Original Submission Date:

Reporting Person:

FOLEY TODD
C/O MPM ASSET MANAGEMENT
450 KENDALL STREET CAMBRIDGE, MA 02142

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-11-20 S 141,365 d $22.02 2,933,528 indirect f4
COMMON STOCK 2019-11-21 S 59,466 d $20.50 2,874,062 indirect f7
COMMON STOCK 2019-11-21 S 5,457 d $21.09 2,868,605 indirect f10
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person.
f2 the shares were sold as follows: 136,079 by mpm bioventures v, l.p. ("bv v") and 5,286 by mpm asset management investors bv5 llc ("am bv5"). mpm bioventures v gp llc and mpm bioventures v llc ("bv llc") are the direct and indirect general partners of bv v and bv llc is the manager of am bv5. ansbert gadicke, luke evnin and todd foley are the members of bv llc. the reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
f3 the price in column 4 is a weighted average sale price. the prices actually received ranged from $21.59 to $22.58. the reporting person will provide to the issuer, any security holder of the issuer, or the sec staff, upon request, information regarding the number of shares sold at each price within the range.
f4 shares are held as follows: 2,823,827 by bv v and 109,701 by am bv5. the reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
f5 shares were sold as follows: 57,242 by bv v and 2,224 by am bv5.
f6 the price in column 4 is a weighted average sale price. the prices actually received ranged from $20.00 to $20.99. the reporting person will provide to the issuer, any security holder of the issuer, or the sec staff, upon request, information regarding the number of shares sold at each price within the range.
f7 shares are held as follows: 2,766,585 by bv v and 107,477 by am bv5. the reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
f8 shares were sold as follows: 5,253 by bv v and 204 by am bv5.
f9 the price in column 4 is a weighted average sale price. the prices actually received ranged from $21.00 to $21.28. the reporting person will provide to the issuer, any security holder of the issuer, or the sec staff, upon request, information regarding the number of shares sold at each price within the range.
f10 shares are held as follows: 2,761,332 by bv v and 107,273 by am bv5. the reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
WhaleWisdom Logo

Elevate your investments